| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-066942 |
| cik | 1863127 |
| name | TYRA BIOSCIENCES, INC. |
| sic | 2834 |
| countryba | US |
| stprba | CA |
| cityba | CARLSBAD |
| zipba | 92008 |
| bas1 | 2656 STATE STREET |
| bas2 | |
| baph | (619) 728-4760 |
| countryma | US |
| stprma | CA |
| cityma | CARLSBAD |
| zipma | 92008 |
| mas1 | 2656 STATE STREET |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 831476348 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 16:10:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | tyra-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066942 | 20240331 | Accretion On Marketable Securities Net | -1229000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Availableforsaledebtsecuritiesnetunrealizedloss | -387000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Comprehensive Income Net Of Tax | -18579000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Comprehensive Income Net Of Tax | -28229000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Increase Decrease In Right Of Use Assets And Lease Liabilities Net | 105000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Interest And Other Income | 4130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Liabilities And Stockholders Equity | 363558000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 122980000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20240331 | Net Cash Provided By Used In Operating Activities | -22028000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Nonoperating Income Expense | 3703000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Operating Lease Liability Noncurrent | 5810000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Prepaid Expense And Other Assets Current | 6022000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240131 | Proceeds From Issuance Of Private Placement | 200000000.0000 | USD | 0 | us-gaap/2024 | Plan Name= Two Thousand Twenty Four Private Placement; | ||
| 0000950170-25-066942 | 20240331 | Proceeds From Issuance Of Private Placement | 120558000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 5890000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Personnel Costs; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 955000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-430; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 8023000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Personnel Costs; Title Of Individual= Chief Operating Decision Maker; | Personnel costs include $3.7 million and $2.5 million of stock-based compensation for the three months ended March 31, 2025 and 2024, respectively. | |
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 2293000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-430; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Share Based Compensation | 4115000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Shares Outstanding | 50749945.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20231231 | Stockholders Equity | 368707000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Stockholders Equity | -279458000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20250331 | Vesting Of Options Early Exercised Subject To Repurchase | 3000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Vesting Of Shares Of Common Stock Subject To Repurchase | 17000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Vesting Of Shares Of Common Stock Subject To Repurchase | 17000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -365000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Assets | 363558000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Assets Current | 324566000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066942 | 20250331 | Common Stock Shares Issued | 53089957.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Income Statement Location= Atm Sales Agreement; | ||
| 0000950170-25-066942 | 20250331 | Common Stock Value | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Depreciation Depletion And Amortization | 122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | General And Administrative Expense | 5119000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | General and administrative expenses consist of personnel-related expenses, including stock-based compensation, legal fees, facility-related costs, depreciation, professional and consulting fees and insurance costs. | |
| 0000950170-25-066942 | 20240331 | Increase Decrease In Prepaid Expenses Other | 43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Interest And Other Income | 3703000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Interest And Other Income | 3703000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Issuance Costs Related To Private Placement Included In Accounts Payable And Accrued And Other Current Liabilities | 0.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Issuance Of Common Stock Under Benefit Plans Shares | 135972.0000 | shares | 1 | 0000950170-25-066942 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 249475000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 218222000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 218222000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Net Cash Provided By Used In Operating Activities | -25458000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Net Income Loss | -28147000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20250331 | Other Accrued Liabilities Current | 11320000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Other Liabilities Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Property Plant And Equipment Net | 1522000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 839000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Development Programs; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 1465000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-200; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Restricted Cash And Cash Equivalents | 1000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Stockholders Equity | -251311000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20250331 | Stockholders Equity | 688000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20241231 | Accounts Payable Current | 590000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Cash And Cash Equivalents At Carrying Value | 254366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Cash And Cash Equivalents At Carrying Value | 91966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 255366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240131 | Common Stock Shares Issued | 4780846.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Plan Name= Two Thousand Twenty Four Private Placement; Subsidiary Sale Of Stock= Pre Funded Warrants; | ||
| 0000950170-25-066942 | 20240331 | Earnings Per Share Basic | -0.3500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Earnings Per Share Diluted | -0.4700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Increase Decrease In Right Of Use Assets And Lease Liabilities Net | 22000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Issuance Costs Related To Private Placement Included In Accounts Payable And Accrued And Other Current Liabilities | 251000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Issuance Of Common Stock Under Benefit Plans | 484000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Issuance Of Pre Funded Warrants Under Private Placement | 79022000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Issuance Of Pre Funded Warrants Under Private Placement | 79022000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20240331 | Net Income Loss | -18192000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -82000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Other Liabilities Noncurrent | 3000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Proceeds From Issuance Of Common Stock Under Benefit Plans | 2187000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 17203000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 4534000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 M U C; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 24964000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Shares Outstanding | 53089957.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20231231 | Stockholders Equity | -164830000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20240331 | Stockholders Equity | 572902000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20241231 | Stockholders Equity | 343151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Stockholders Equity | 593687000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20240331 | Vesting Of Shares Of Common Stock Subject To Repurchase Share | 27904.0000 | shares | 1 | 0000950170-25-066942 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 59336550.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 688000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 6422000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 6422000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Availableforsaledebtsecuritiesnetunrealizedloss | -82000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 196360000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Common Stock Shares Outstanding | 53089957.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Depreciation Depletion And Amortization | 143000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Earnings Per Share Diluted | -0.3500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Interest And Other Income | 4130000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Issuance Of Common Stock Under Benefit Plans Shares | 335626.0000 | shares | 1 | 0000950170-25-066942 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Liabilities And Stockholders Equity | 343476000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 126495000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 126495000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 124169000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20240331 | Net Cash Provided By Used In Financing Activities | 200315000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | 200000000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 1300000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Facilities And Other Costs; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 904000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-200; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20241231 | Restricted Cash Noncurrent | 1000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20231231 | Stockholders Equity | 4000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Accounts Payable Current | 2500000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 92966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 8755000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Earnings Per Share Basic | -0.4700 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Increase Decrease In Prepaid Expenses Other | 2667000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Issuance Of Common Stock Pursuant To Pre Funded Warrant Exercise | 2000069.0000 | shares | 1 | 0000950170-25-066942 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20241231 | Liabilities | 20407000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Liabilities Current | 14246000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 122980000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 94053000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20240331 | Net Income Loss | -18192000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20240331 | Operating Expenses | 22322000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Operating Income Loss | -31850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | 169000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Payments To Acquire Marketable Securities | 11791000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Payments To Acquire Marketable Securities | 6870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Payments To Acquire Property Plant And Equipment | 136000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Prepaid Expense And Other Assets Current | 5623000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | 0.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Proceeds From Issuance Of Private Placement | 120557000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-066942 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 38910000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 0.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 N M I B C; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Restricted Cash Noncurrent | 1000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Right Of Use Asset | 5946000.0000 | USD | 0 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Share Based Compensation | 6422000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20231231 | Stockholders Equity | 204262000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Stockholders Equity | -6000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20240331 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20241231 | Stockholders Equity | 770000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20241231 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 770000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Additional Paid In Capital Common Stock | 593687000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4115000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Assets Current | 347463000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 59006000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 101721000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -6906000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 124169000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Net Income Loss | -28147000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Net Income Loss | -28147000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Nonoperating Income Expense | 4130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Operating Lease Liability Current | 426000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Operating Lease Liability Noncurrent | 5696000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Other Accrued Liabilities Current | 13592000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Other Assets Noncurrent | 7376000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -387000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Payments To Acquire Property Plant And Equipment | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Property Plant And Equipment Net | 1651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 1376000.0000 | USD | 1 | us-gaap/2024 | Business Segments= F G F R Discovery; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 514000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Other Development Programs; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 3587000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 A C H; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 3255000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 M U C; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Restricted Cash And Cash Equivalents | 1000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Retained Earnings Accumulated Deficit | -251311000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Right Of Use Asset | 6068000.0000 | USD | 0 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20231231 | Stockholders Equity | 381000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Loss; | ||
| 0000950170-25-066942 | 20240331 | Stockholders Equity | 389879000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Stock Issued During Period Shares New Issues | 9286023.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-066942 | 20240331 | Vesting Of Options Early Exercised Subject To Repurchase | 17000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20240331 | Payments Of Stock Issuance Costs | 200000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Warrant; | ||
| 0000950170-25-066942 | 20240331 | Payments Of Stock Issuance Costs | 200000.0000 | USD | 1 | us-gaap/2024 | Class Of Stock= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-066942 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Availableforsaledebtsecuritiesnetunrealizedloss | -82000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-066942 | 20241231 | Common Stock Shares Issued | 50754262.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Common Stock Shares Outstanding | 50749945.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Common Stock Value | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Liabilities | 19942000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Liabilities Current | 14594000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20240331 | Net Cash Provided By Used In Investing Activities | 18073000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Net Income Loss | -18192000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Operating Lease Liability Current | 412000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | 0.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Proceeds From Issuance Of Private Placement | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-066942 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 30000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 1405000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 A C H; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Research And Development Expense | 17203000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 24964000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 1405000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Facilities And Other Costs; Title Of Individual= Chief Operating Decision Maker; | Facilities and other costs consist of research consumables, facility-related costs, depreciation and costs not attributed to a specific program. | |
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 1290000.0000 | USD | 1 | us-gaap/2024 | Business Segments= T Y R A-300 N M I B C; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20250331 | Retained Earnings Accumulated Deficit | -279458000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20231231 | Shares Outstanding | 43024634.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20240331 | Shares Outstanding | 52474533.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Stockholders Equity | 602299000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20240131 | Stock Issued During Period Shares New Issues | 9286023.0000 | shares | 0 | us-gaap/2024 | Plan Name= Two Thousand Twenty Four Private Placement; Subsidiary Sale Of Stock= Private Placement; | ||
| 0000950170-25-066942 | 20250331 | Vesting Of Shares Of Common Stock Subject To Repurchase Share | 4317.0000 | shares | 1 | 0000950170-25-066942 | Equity Components= Common Stock; | ||
| 0000950170-25-066942 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 59336550.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | General And Administrative Expense | 5119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Accretion On Marketable Securities Net | -866000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Additional Paid In Capital Common Stock | 602299000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4115000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Assets | 343476000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Availableforsaledebtsecuritiesnetunrealizedloss | -387000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Cash And Cash Equivalents At Carrying Value | 100721000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Common Stock Shares Issued | 2000069.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Related Party Transactions By Related Party= Boxer Capital Llc; Subsidiary Sale Of Stock= Pre Funded Warrants; | ||
| 0000950170-25-066942 | 20250331 | General And Administrative Expense | 6886000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | General And Administrative Expense | 6886000.0000 | USD | 1 | us-gaap/2024 | Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Issuance Of Common Stock Under Benefit Plans | 484000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20250331 | Issuance Of Common Stock Under Benefit Plans | 2187000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Issuance Of Common Stock Under Benefit Plans | 2187000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 249475000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20241231 | Marketable Securities | 249475000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 94053000.0000 | USD | 0 | us-gaap/2024 | Cash And Cash Equivalents= U S Government Corporations And Agencies Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Marketable Securities | 218222000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0000950170-25-066942 | 20250331 | Net Cash Provided By Used In Financing Activities | 2187000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Net Cash Provided By Used In Investing Activities | 32026000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Operating Expenses | 31850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Operating Income Loss | -22322000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Other Assets Noncurrent | 10442000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Proceeds From Issuance Of Common Stock Under Benefit Plans | 484000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Research And Development Expense | 3132000.0000 | USD | 1 | us-gaap/2024 | Business Segments= F G F R Discovery; Title Of Individual= Chief Operating Decision Maker; | ||
| 0000950170-25-066942 | 20240331 | Stockholders Equity | -183022000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-066942 | 20250331 | Stockholders Equity | 323534000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20250331 | Vesting Of Shares Of Common Stock Subject To Repurchase | 3000.0000 | USD | 1 | 0000950170-25-066942 | |||
| 0000950170-25-066942 | 20250331 | Vesting Of Shares Of Common Stock Subject To Repurchase | 3000.0000 | USD | 1 | 0000950170-25-066942 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-066942 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 52228934.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-066942 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 52228934.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expenses, Other | Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Issuance Of Common Stock Under Benefit Plans | 0000950170-25-066942 | 1 | 0 | monetary | D | D | Issuance of Common Stock Under Benefit Plans | Issuance of Common Stock Under Benefit Plans |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Vesting Of Shares Of Common Stock Subject To Repurchase | 0000950170-25-066942 | 1 | 0 | monetary | D | C | Vesting Of Shares Of Common Stock Subject To Repurchase | Vesting of shares of common stock subject to repurchase. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Vesting Of Options Early Exercised Subject To Repurchase | 0000950170-25-066942 | 1 | 0 | monetary | D | C | Vesting of options early exercised subject to repurchase | Vesting of options early exercised subject to repurchase |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Issuance Of Common Stock Under Benefit Plans | 0000950170-25-066942 | 1 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock Under Benefit Plans | Proceeds from Issuance of Common Stock Under Benefit Plans |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Issuance Costs Related To Private Placement Included In Accounts Payable And Accrued And Other Current Liabilities | 0000950170-25-066942 | 1 | 0 | monetary | D | C | Issuance costs related to Private Placement included in accounts payable and accrued and other current liabilities | Issuance costs related to Private Placement included in accounts payable and accrued and other current liabilities |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Right Of Use Assets And Lease Liabilities Net | 0000950170-25-066942 | 1 | 0 | monetary | D | D | Increase Decrease In Right Of Use Assets And Lease Liabilities Net | Increase decrease in right of use assets and lease liabilities net. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Vesting Of Shares Of Common Stock Subject To Repurchase Share | 0000950170-25-066942 | 1 | 0 | shares | D | Vesting Of Shares Of Common Stock Subject To Repurchase, Share | Vesting Of Shares Of Common Stock Subject To Repurchase, Share | |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Interest And Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities | Amount of investment in marketable security. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | 0000950170-25-066942 | 1 | 0 | monetary | D | C | Payments of issuance costs for common stock and pre-funded warrants from Private Placement | Payments of issuance costs for common stock and pre-funded warrants from Private Placement |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Accretion On Marketable Securities Net | 0000950170-25-066942 | 1 | 0 | monetary | D | D | Accretion on marketable securities, net | Accretion on marketable securities, net |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Issuance Of Pre Funded Warrants Under Private Placement | 0000950170-25-066942 | 1 | 0 | monetary | D | C | Issuance Of Pre Funded Warrants Under Private Placement | Issuance Of Pre Funded Warrants Under Private Placement |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Issuance Of Common Stock Pursuant To Pre Funded Warrant Exercise | 0000950170-25-066942 | 1 | 0 | shares | D | Issuance Of Common Stock Pursuant To Pre Funded Warrant Exercise | Issuance Of Common Stock Pursuant To Pre Funded Warrant Exercise | |
| Issuance Of Common Stock Under Benefit Plans Shares | 0000950170-25-066942 | 1 | 0 | shares | D | Issuance of Common Stock Under Benefit Plans Shares | Issuance of common stock shares under benefit plans. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Restricted Cash And Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalents | Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Right Of Use Asset | 0000950170-25-066942 | 1 | 0 | monetary | I | D | Right Of Use Asset | Right of Use Asset. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Availableforsaledebtsecuritiesnetunrealizedloss | 0000950170-25-066942 | 1 | 0 | monetary | D | D | AvailableForSaleDebtSecuritiesNetUnrealizedLoss | AvailableForSaleDebtSecuritiesNetUnrealizedLoss |
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | 0000950170-25-066942 | 1 | 0 | monetary | D | D | Proceeds from issuance of common stock and pre-funded warrants from Private Placement | Proceeds from issuance of common stock and pre-funded warrants from Private Placement |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-066942 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-066942 | 2 | 26 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0000950170-25-066942 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-066942 | 2 | 4 | BS | 0 | H | Marketable Securities | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-066942 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-066942 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-066942 | 2 | 7 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-066942 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-066942 | 2 | 9 | BS | 0 | H | Right Of Use Asset | 0000950170-25-066942 | Right-of-use asset | 0 |
| 0000950170-25-066942 | 2 | 10 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other long-term assets | 0 |
| 0000950170-25-066942 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-066942 | 2 | 14 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-066942 | 2 | 15 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Lease liabilities, current | 0 |
| 0000950170-25-066942 | 2 | 16 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-066942 | 2 | 17 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-066942 | 2 | 18 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease liabilities, noncurrent | 0 |
| 0000950170-25-066942 | 2 | 19 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0000950170-25-066942 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-066942 | 2 | 21 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 10) | 0 |
| 0000950170-25-066942 | 2 | 23 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.0001 par value; 50,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024. | 0 |
| 0000950170-25-066942 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 500,000,000 shares authorized at March 31, 2025 and December 31, 2024; 53,089,957 and 50,754,262 shares issued at March 31, 2025 and December 31, 2024, respectively, and 53,089,957 and 50,749,945 shares outstanding at March 31, 2025 and December 31, 2024, respectively. | 0 |
| 0000950170-25-066942 | 2 | 25 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-066942 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-066942 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-066942 | 3 | 5 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0000950170-25-066942 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0000950170-25-066942 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0000950170-25-066942 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0000950170-25-066942 | 3 | 9 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-066942 | 3 | 10 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-066942 | 3 | 11 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-066942 | 3 | 12 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-066942 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-066942 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0000950170-25-066942 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-066942 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-066942 | 4 | 7 | IS | 0 | H | Interest And Other Income | us-gaap/2024 | Interest and other income, net | 0 |
| 0000950170-25-066942 | 4 | 8 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income | 0 |
| 0000950170-25-066942 | 4 | 9 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-066942 | 4 | 10 | IS | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized loss on marketable securities available-for-sale, net | 0 |
| 0000950170-25-066942 | 4 | 11 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0000950170-25-066942 | 4 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0000950170-25-066942 | 4 | 13 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0000950170-25-066942 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average Number of shares outstanding, Basic | 0 |
| 0000950170-25-066942 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares number of shares outstanding, Diluted | 0 |
| 0000950170-25-066942 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-066942 | 5 | 16 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0000950170-25-066942 | 5 | 17 | EQ | 0 | H | Issuance Of Pre Funded Warrants Under Private Placement | 0000950170-25-066942 | Issuance of pre-funded warrants, net of issuance costs | 0 |
| 0000950170-25-066942 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock under Private Placement, net of issuance costs, Shares | 0 |
| 0000950170-25-066942 | 5 | 19 | EQ | 0 | H | Issuance Of Common Stock Pursuant To Pre Funded Warrant Exercise | 0000950170-25-066942 | Issuance of common stock pursuant to pre-funded warrant exercise, shares | 0 |
| 0000950170-25-066942 | 5 | 20 | EQ | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Issuance of common stock under Private Placement, net of issuance costs | 0 |
| 0000950170-25-066942 | 5 | 21 | EQ | 0 | H | Issuance Of Common Stock Under Benefit Plans Shares | 0000950170-25-066942 | Issuance of common stock under benefit plans, Shares | 0 |
| 0000950170-25-066942 | 5 | 22 | EQ | 0 | H | Issuance Of Common Stock Under Benefit Plans | 0000950170-25-066942 | Issuance of common stock under benefit plans | 0 |
| 0000950170-25-066942 | 5 | 23 | EQ | 0 | H | Vesting Of Shares Of Common Stock Subject To Repurchase | 0000950170-25-066942 | Vesting of shares of common stock subject to repurchase | 0 |
| 0000950170-25-066942 | 5 | 24 | EQ | 0 | H | Vesting Of Shares Of Common Stock Subject To Repurchase Share | 0000950170-25-066942 | Vesting of shares of common stock subject to repurchase, Share | 0 |
| 0000950170-25-066942 | 5 | 25 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-066942 | 5 | 26 | EQ | 0 | H | Availableforsaledebtsecuritiesnetunrealizedloss | 0000950170-25-066942 | Unrealized loss on marketable securities available-for-sale, net | 0 |
| 0000950170-25-066942 | 5 | 27 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-066942 | 5 | 28 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-066942 | 5 | 29 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0000950170-25-066942 | 6 | 13 | EQ | 1 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payments of Stock Issuance Costs | 0 |
| 0000950170-25-066942 | 7 | 4 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-066942 | 7 | 6 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation | 0 |
| 0000950170-25-066942 | 7 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0000950170-25-066942 | 7 | 8 | CF | 0 | H | Accretion On Marketable Securities Net | 0000950170-25-066942 | Accretion on marketable securities, net | 0 |
| 0000950170-25-066942 | 7 | 10 | CF | 0 | H | Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0000950170-25-066942 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued expenses and other liabilities | 0 |
| 0000950170-25-066942 | 7 | 12 | CF | 0 | H | Increase Decrease In Right Of Use Assets And Lease Liabilities Net | 0000950170-25-066942 | Right-of-use assets and lease liabilities, net | 0 |
| 0000950170-25-066942 | 7 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-066942 | 7 | 15 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-066942 | 7 | 16 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Maturities of marketable securities | 0 |
| 0000950170-25-066942 | 7 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-066942 | 7 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-066942 | 7 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock Under Benefit Plans | 0000950170-25-066942 | Proceeds from issuances of common stock under benefit plans | 0 |
| 0000950170-25-066942 | 7 | 21 | CF | 0 | H | Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | 0000950170-25-066942 | Proceeds from issuance of common stock and pre-funded warrants from Private Placement | 0 |
| 0000950170-25-066942 | 7 | 22 | CF | 0 | H | Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | 0000950170-25-066942 | Payments of issuance costs for common stock and pre-funded warrants from Private Placement | 1 |
| 0000950170-25-066942 | 7 | 23 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-066942 | 7 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net cash increase for the period | 0 |
| 0000950170-25-066942 | 7 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of the period | 0 |
| 0000950170-25-066942 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of the period | 0 |
| 0000950170-25-066942 | 7 | 28 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-066942 | 7 | 29 | CF | 0 | H | Restricted Cash And Cash Equivalents | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-066942 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-066942 | 7 | 32 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Purchases of equipment included in accounts payable and accrued and other current liabilities | 0 |
| 0000950170-25-066942 | 7 | 33 | CF | 0 | H | Vesting Of Options Early Exercised Subject To Repurchase | 0000950170-25-066942 | Vesting of options early exercised subject to repurchase | 0 |
| 0000950170-25-066942 | 7 | 34 | CF | 0 | H | Issuance Costs Related To Private Placement Included In Accounts Payable And Accrued And Other Current Liabilities | 0000950170-25-066942 | Issuance costs for common stock and pre-funded warrants from Private Placement included in accounts payable and accrued expenses and other current liabilities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |